Friday's down market day was a welcome and needed pause, independent investment consultant David Darst told CNBC. Here's when he would buy.» Read More
CNBC's Sharon Epperson reports on the correlation between market moves and movement in 401(k) investments.
Discussing the consumer story amid a stronger dollar and lower oil prices, with John Spallanzani, GFI Group; "Fast Money's" Tim Seymour; and Marc Lopresti, Lopresti Law Group.
CNBC's Tyler Mathisen reports a former CNBC colleague Terry Keenan has died. Keenan worked for CNBC between 1995 and 1998 as a reporter and anchor.
Discussing what really moved the bond market one week ago, and what we're hearing from the Fed, with Jeff Rosenberg, BlackRock.
Digging into the market rally, with John Spallanzani, GFI Group.
Discussing current market conditions, and global economic data, with independent investment consultant David Darst and CNBC's Bob Pisani.
According to Dow Jones citing sources familiar, Roku is working on a confidential IPO. CNBC's Dominic Chu has the details.
Ralph Acampora, Altaira senior managing director, and Carter Worth, Sterne Agee, debate the bull and the bear case on the markets.
Medical supply company Edwards Lifesciences is currently the best performer in the S&P 500. CNBC's Dominic Chu outlines some of Friday's biggest movers.
Shire CEO Flemming Ornskov, discusses the company's break up with AbbVie, tax inversion rules, and proceeding as an independent company.
Discussing Ebola protocols and if the U.S. could better improve Ebola detection standards, with missionary nurse and Ebola survivor Nancy Writebol.
Any underperforming company can come under attack from an activist investor. Hedge funds ponder whether Amazon will be targeted next.
Amazon's huge earnings miss may be the last straw for investors.
Despite the swings in the market, favoring fixed-income or bond funds over equity or stocks in a retirement account could be a mistake. Here's why.
CNBC.com Managing Editor Allen Wastler reports Ebola and Amazon's earnings miss are the hottest topics on CNBC.com.
Matt Maloney, GrubHub CEO and co-founder, discusses what is driving the company's growth and why customers stick with the online food delivery site.
Rodney Martin Jr., Voya CEO, is strongly encouraging people to save frequently and consistently over a long period of time with its new "Born to Save" program.
Dr. Scott Gottlieb, former FDA Deputy Commissioner, provides insight into the doctor in New York City being tested, who treated Ebola patients in West Africa.
Michael Roth, Interpublic Group CEO, discusses what drove positive earnings, with CNBC's Kelly Evans and Julia Boorstin.
Here's an outfit that missed Wall Street expectations seven out of the last nine quarters, but the stock still commands a premium in the market.